WP Advisors LLC cut its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 77.2% during the third quarter, Holdings Channel.com reports. The institutional investor owned 3,092 shares of the exchange traded fund’s stock after selling 10,452 shares during the quarter. WP Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $305,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds also recently added to or reduced their stakes in the company. Quintet Private Bank Europe S.A. purchased a new stake in SPDR S&P Biotech ETF in the third quarter valued at $40,000. ORG Partners LLC purchased a new stake in SPDR S&P Biotech ETF in the second quarter valued at $40,000. ORG Wealth Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF in the third quarter worth about $44,000. Waldron Private Wealth LLC acquired a new position in shares of SPDR S&P Biotech ETF in the third quarter worth about $54,000. Finally, Resources Management Corp CT ADV raised its position in shares of SPDR S&P Biotech ETF by 30.3% in the second quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after acquiring an additional 138 shares during the period.
SPDR S&P Biotech ETF Stock Performance
Shares of SPDR S&P Biotech ETF stock opened at $91.83 on Monday. The firm has a 50-day simple moving average of $98.95 and a two-hundred day simple moving average of $96.17. The company has a market cap of $7.00 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a fifty-two week low of $69.32 and a fifty-two week high of $105.47.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Time to Buy These Up-and-Coming Software Firms?
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Alibaba Stock: Why Earnings Make It a Buy Despite the Recent Dip
- Consumer Staples Stocks, Explained
- Plug Power Stock: Mixed Results Adds To Volatilty
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.